ArticleScientific reports2025

Investigating of harmane, harmine, and norharman as inhibitors of MDR1 and MRP1 to overcome chemotherapy resistance in cancer cells.

Neda Abdi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.